Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Glaucoma and Retinopathy Screening Study

NCT: NCT06882356 · RECRUITING

NCT IDNCT06882356
StatusRECRUITING
Start Date2025-07-16
Completion2030-09
SponsorMassachusetts Eye and Ear Infirmary (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma. Participants will: Have an image of their fundus (back of the eye) taken as part of their diabetic eye screening Have a measurement of their eye pressure If needed, have a test of their side vision using a headset

Frequently Asked Questions

What is The Glaucoma and Retinopathy Screening Study?

The Glaucoma and Retinopathy Screening Study is a clinical trial registered under NCT06882356. Current status: RECRUITING.

What is the status of NCT06882356?

The current status of NCT06882356 (The Glaucoma and Retinopathy Screening Study) is: RECRUITING.

When did The Glaucoma and Retinopathy Screening Study start?

The Glaucoma and Retinopathy Screening Study started on 2025-07-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.